Akums Drugs And Pharmaceuticals Peer Comparison

NSE: AKUMS | BSE: 544222

₹769.95

₹0.65 (0.08%)

As on 14-Oct-2026IST

Market cap

₹12,109 Cr

Revenue (TTM)

₹4,502 Cr

P/E Ratio

41.5

P/B Ratio

3.5

Div. Yield

0.4 %

Edit

	Akums Drugs And Pharmaceuticals	Acutaas Chemicals	Alembic Pharma	Cohance Lifesciences	Granules India	Natco Pharma	Onesource Specialty Pharma	Piramal Pharma	Rubicon Research	Wockhardt
Market cap (₹ Cr)	12,109	25,879	15,574	17,066	22,039	15,360	16,563	25,808	25,250	32,278
Revenue (₹ Cr)	4,502	1,462	7,784	2,142	5,632	3,485	1,543	9,205	1,936	3,564
Net Profit (₹ Cr)	292.69	387.35	688.47	58.53	662.35	1,013.80	-48.62	-371.81	288.22	414.00
Net Margin (%)	6.32	26.01	8.77	2.69	11.75	26.82	-3.12	-3.93	14.79	11.23
RoE (%)	9.44	25.18	14.02	3.29	14.34	12.81	-0.61	-3.85	29.77	8.38
Price to Earnings	41.51	67.01	22.46	160.65	33.27	13.42	--	--	87.61	78.92
Price-To-Book	3.55	15.00	2.66	4.43	4.50	1.64	2.83	3.22	18.81	6.41

Income Statement (₹ Cr)

	Akums Drugs And Pharmaceuticals	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Operating Revenue	4,501.61	3,564.00	9,205.28	1,461.80	1,935.80
Total Income	4,633.99	3,686.00	9,449.59	1,489.25	1,948.58
Total Expenditure	3,933.88	2,792.00	8,195.15	919.25	1,485.56
EBITDA	567.73	772.00	1,010.13	542.56	450.24
Depreciation	158.70	226.00	857.51	37.68	50.83
EBIT	409.04	546.00	152.62	504.88	399.41
Interest	95.69	217.00	342.73	3.77	40.84
Other Income	132.37	122.00	244.31	27.45	12.78
Exceptional Items	-20.02	12.00	-216.88	0.00	0.00
Profit before Tax	425.69	463.00	-162.68	528.56	371.35
Provision for Tax	133.00	49.00	209.13	141.21	83.14
Profit after Tax	292.69	414.00	-371.81	387.35	288.22

	Akums Drugs And Pharmaceuticals	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Shareholder's Funds	3,313.35	4,940.00	8,162.62	1,653.56	1,288.82
Minority Interest	-0.97	-5.00	0.00	-1.13	0.00
Non-Current Liabilities	1,021.09	1,712.00	5,044.14	42.40	202.03
Current Liabilities	1,094.76	1,622.00	4,758.28	230.82	835.87
Total Liabilities	5,429.26	8,578.00	17,723.32	1,983.96	2,326.71

	Akums Drugs And Pharmaceuticals	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Non-Current Assets	1,635.38	5,343.00	10,211.52	1,026.85	519.60
Current Assets	3,559.86	2,606.00	7,191.66	881.27	1,681.81
Total Assets	5,429.26	8,578.00	17,723.32	1,983.96	2,326.71
Total Debt*	72.95	2,125.00	5,495.48	26.49	259.37
Net Current Assets	2,465.10	984.00	2,433.38	650.46	845.94
Contingent Liabilities	99.40	768.26	95.72	17.25	19.09

	Akums Drugs And Pharmaceuticals	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Cash From Operating Activities	1,181.20	390.00	1,652.60	292.17	205.05
Cash Flow from Investing Activities	-930.27	-241.00	-826.03	-265.94	-409.72
Cash from Financing Activities	33.88	-54.00	-38.98	4.10	283.07
Net Cash Inflow / Outflow	284.81	95.00	787.59	30.33	78.39

	Akums Drugs And Pharmaceuticals	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
ROCE (%)	14.77	6.79	1.24	32.42	29.22
ROE (%)	9.44	8.38	-3.85	25.18	29.77
ROA (%)	6.12	4.94	-2.21	21.93	24.77
EBIT Margin (%)	9.09	15.32	1.66	34.54	20.63
Net Margin (%)	6.32	11.23	-3.93	26.01	14.79
Cash Profit Margin (%)	0.00	0.00	0.00	0.00	0.00

	Akums Drugs And Pharmaceuticals	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Revenue Growth (%)	9.18	18.37	0.78	40.90	46.65
EBIT Growth (%)	32.32	252.26	-70.53	124.50	62.13
Net Profit Growth (%)	-15.71	377.85	-1,383.43	104.15	89.49
EPS Growth (%)	-4.44	1,001.33	-484.84	42.32	78.60
Book Value Growth (%)	8.74	13.47	0.33	26.03	144.31

	Akums Drugs And Pharmaceuticals	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Price / Earnings	39.69	81.00	-82.48	67.01	86.26
Price / Book Value	3.55	6.41	3.22	15.00	18.81
Dividend Yield (%)	0.39	0.00	0.00	0.08	0.10
EV/EBITDA	18.50	43.71	29.65	47.33	55.89
Market Cap (₹ Cr)	7,135.27	19,071.62	18,108.89	20,944.75	12,753.19

	Akums Drugs And Pharmaceuticals	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Debt to Equity	0.00	0.31	0.53	0.02	0.11
Short term debt to equity ratio	0.02	0.09	0.09	0.02	0.05
Current Ratio	3.25	1.61	1.51	3.82	2.01
Quick Ratio	2.56	1.06	0.87	2.82	1.14
Interest Coverage	5.45	3.13	0.53	141.16	10.09

	Akums Drugs And Pharmaceuticals	Wockhardt	Piramal Pharma	Acutaas Chemicals	Rubicon Research
Debtors to sales (%)	17.70	16.50	23.44	24.80	26.28
Asset Turnover	0.94	0.43	0.55	0.83	1.66
Receivable days	65.60	58.75	78.20	88.98	40.13
Inventory Days	60.15	75.82	93.30	56.04	60.29
Payable days	90.39	186.21	226.14	99.95	232.47
Cash Conversion Cycle	35.36	-51.64	-54.64	45.07	-132.04

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.